[HTML][HTML] Peptide and peptide-based inhibitors of SARS-CoV-2 entry

D Schütz, YB Ruiz-Blanco, J Münch, F Kirchhoff… - Advanced drug delivery …, 2020 - Elsevier
To date, no effective vaccines or therapies are available against the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the causative pandemic agent of the coronavirus …

Inhibitors of SARS-CoV-2 entry: current and future opportunities

S Xiu, A Dick, H Ju, S Mirzaie, F Abdi… - Journal of medicinal …, 2020 - ACS Publications
Recently, a novel coronavirus initially designated 2019-nCoV but now termed SARS-CoV-2
has emerged and raised global concerns due to its virulence. SARS-CoV-2 is the etiological …

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein

X Fan, D Cao, L Kong, X Zhang - Nature communications, 2020 - nature.com
Global emergencies caused by the severe acute respiratory syndrome coronavirus (SARS-
CoV), Middle-East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2 …

MERS-CoV spike protein: targets for vaccines and therapeutics

Q Wang, G Wong, G Lu, J Yan, GF Gao - Antiviral research, 2016 - Elsevier
The disease outbreak caused by Middle East respiratory syndrome coronavirus (MERS-
CoV) is still ongoing in the Middle East. Over 1700 people have been infected since it was …

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus …

G Zhao, L Du, C Ma, Y Li, L Li, VKM Poon, L Wang… - Virology journal, 2013 - Springer
Background Evidence points to the emergence of a novel human coronavirus, Middle East
respiratory syndrome coronavirus (MERS-CoV), which causes a severe acute respiratory …

Antiviral peptides against Coronaviridae family: A review

H Heydari, R Golmohammadi, R Mirnejad… - Peptides, 2021 - Elsevier
The Coronaviridae family comprises large enveloped single-stranded RNA viruses. The
known human-infecting coronaviruses; severe acute respiratory syndrome coronavirus …

[HTML][HTML] Discovery of new fusion inhibitor peptides against SARS-CoV-2 by targeting the spike S2 subunit

M Kandeel, M Yamamoto, H Tani… - Biomolecules & …, 2021 - ncbi.nlm.nih.gov
A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
caused a worldwide pandemic. Our aim in this study is to produce new fusion inhibitors …

[HTML][HTML] Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain

D Barh, S Tiwari, BS Andrade, M Giovanetti… - …, 2020 - ncbi.nlm.nih.gov
Background: There are no known medicines or vaccines to control the COVID-19 pandemic
caused by SARS-CoV-2 (nCoV). Antiviral peptides are superior to conventional drugs and …

Targeting the SARS-CoV-2 HR1 with small molecules as inhibitors of the fusion process

D Gentile, A Coco, V Patamia, C Zagni… - International Journal of …, 2022 - mdpi.com
The rapid and global propagation of the novel human coronavirus that causes severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced an immediate urgency to …

Antiviral activity of Piscidin 1 against pseudorabies virus both in vitro and in vivo

H Hu, N Guo, S Chen, X Guo, X Liu, S Ye, Q Chai… - Virology journal, 2019 - Springer
Background Swine-origin virus infection spreading widely could cause significant economic
loss to porcine industry. Novel antiviral agents need to be developed to control this situation …